Increasing Number of Clinical Trials Driving Medical Affairs Outsourcing Market at a CAGR of Around 14%

• Overview
• Table of Content
• Research Methodology
• Download Free Sample

The Global Medical Affairs Outsourcing Market size was valued at around USD 2.2 billion in 2024 and is projected to reach USD 4.8 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 14% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The main reason behind this growth is the high quality of medical affairs provided by Clinical Research Organizations, which helps life science companies, especially pharmaceuticals, in developing a high-quality product and ensuring its successful market launch through proper explanatory publications, and that too at reasonable prices.

Moreover, huge investments are made by multiple life science companies in their R&D processes, with pharmaceuticals as the most prominent industry. For instance, in 2023, Merck & Co. was the top company in the world in terms of R&D expenditures, with a spending of around USD30.5 billion. Also, GSK announced the expansion of its facility in Pennsylvania, US with an investment of around USD800 million to enhance its R&D processes and increase manufacturing. Such investments directly correlate with the high need for medical affairs as these services help life science companies enhance product development and promote their impact, functionality, and safety among the target healthcare providers and patients.

Furthermore, various new diseases emerged at regular intervals all across the world, such as Oropouche disease and HMPV disease were noted in 2024. To address such outspreads, companies have to make drugs that have high efficacy and that too in less time. As a result, medical affairs help them in achieving such goals with their high expertise in this field. Also, they monitor the impact of medicines on humans after use and keep the researchers updated with those parameters. They also publish articles in the news and magazines to promote the benefits of medicines, hence increasing their visibility among doctors and patients.

Therefore, the market has experienced high growth due to an increasing number of clinical trials for various products, which is further fueled by investments made by companies in R&D processes, and this trend is expected to continue in the forecast period as well, further states the research report, “Global Medical Affairs Outsourcing Market Analysis, 2025.”

Global Medical Affairs Outsourcing Market Segmentation Analysis

Medical Writing & Publishing is the Most Preferred Service

Based on the type of services, the market is further bifurcated into Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons, Medical Information, and others. Here, medical writing and publishing lead the market with a share of around 38%. This is because promoting the use of a drug is the main challenge faced by any pharmaceutical company, and publications help them in addressing this problem. This is because writing reports that contain the benefits of medicine, compliance with regulations, research process, etc., and publishing them in news, websites, and magazines increases the visibility of the product among the target audience.

Therefore, to promote the functional benefits of products among the target audience, medical writing, and publishing have been the most used medical affairs service, and its dominance is expected to continue in the future years as well.

North America Leads the Global Medical Affairs Outsourcing Industry

Regionally, North America dominates the market with a market share of around 38%. This is because of the presence of a very high number of life science companies in this region that make huge investments in clinical trials. For instance, around 1,86,497 clinical trials have been done by the US from 1999 to 2024, making it the top country in terms of clinical trials. As a result, they also increase the demand for medical affairs in this region as these services are beneficial for the successful operation and monitoring of clinical trials. They also promote the products through articles and publications after their successful development.

Therefore, the presence of numerous life science companies in North America has increased the demand for medical affairs in this region, and this dominance is expected to remain in the future as well.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including IQVIA, ICON plc, Syneos Health, The Medical Affairs Company, Ashfield Medical Communications, Wuxi Clinical, Thermo Fisher Scientific, Indegene, SGS SA, Parexel, Charles River Associates, Inizio Medical, Medpace, Biomapas, Excelya, and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & service adoption?
5. How has the competition been shaping up across the regions?
6. How have buying behavior, customer inclination, and expectations from services been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?